Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
31,500
Employees31,500
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
31,500
Employees31,500

AMGN Key Statistics

Market cap
200.81B
Market cap200.81B
Price-Earnings ratio
25.95
Price-Earnings ratio25.95
Dividend yield
2.58%
Dividend yield2.58%
Average volume
3.37M
Average volume3.37M
High today
$374.77
High today$374.77
Low today
$368.03
Low today$368.03
Open price
$370.90
Open price$370.90
Volume
1.37M
Volume1.37M
52 Week high
$385.12
52 Week high$385.12
52 Week low
$261.43
52 Week low$261.43

Stock Snapshot

With a market cap of 200.81B, Amgen(AMGN) trades at $372.90. The stock has a price-to-earnings ratio of 25.95 and currently yields dividends of 2.6%.

During the trading session on 2026-02-17, Amgen(AMGN) shares reached a daily high of $374.77 and a low of $368.03. At a current price of $372.90, the stock is +1.3% higher than the low and still -0.5% under the high.

Trading volume for Amgen(AMGN) stock has reached 1.37M, versus its average volume of 3.37M.

Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $385.12 and a low of $261.43.

Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $385.12 and a low of $261.43.

AMGN News

Simply Wall St 2d
A Look At Amgen Valuation After Strong Q4 Results And New UPLIZNA Approval

Advertisement What Amgen’s latest quarter and new approval could mean for investors Amgen (AMGN) is back on investors’ radar after reporting fourth quarter an...

A Look At Amgen Valuation After Strong Q4 Results And New UPLIZNA Approval
TipRanks 4d
Amgen files automatic mixed securities shelf

16:46 EST Amgen (AMGN) files automatic mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking financial n...

Simply Wall St 5d
UPLIZNA’s Expanded EU Use in Autoimmune Disease Could Be A Game Changer For Amgen

Amgen recently reported that the European Commission approved UPLIZNA (inebilizumab) as an add-on therapy for adults with generalized myasthenia gravis who are...

UPLIZNA’s Expanded EU Use in Autoimmune Disease Could Be A Game Changer For Amgen

Analyst ratings

51%

of 35 ratings
Buy
42.9%
Hold
51.4%
Sell
5.7%

More AMGN News

TipRanks 5d
Amgen downgraded to Hold from Buy at Freedom Capital

Freedom Capital downgraded Amgen (AMGN) to Hold from Buy with a price target of $375, up from $360. The firm views the company’s Q4 report as “strong.” However,...

Nasdaq 6d
Ex-Dividend Reminder: Cencora, Amgen and Oppenheimer Holdings

Looking at the universe of stocks we cover at Dividend Channel, on 2/13/26, Cencora Inc (Symbol: COR), Amgen Inc (Symbol: AMGN), and Oppenheimer Holdings Inc Cl...

Ex-Dividend Reminder: Cencora, Amgen and Oppenheimer Holdings
Simply Wall St 6d
Amgen Is Increasing Its Dividend To $2.52

Amgen Inc.'s ( ) dividend will be increasing from last year's payment of the same period to $2.52 on 6th of March. This makes the dividend yield about the same...

Amgen Is Increasing Its Dividend To $2.52

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.